PANACEA BIOTEC
|
PANACEA BIOTEC Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | -0.19 | -5.43 | 176.05 | -24.11 | -31.72 |
| CEPS(Rs) | 5.75 | 0.88 | 183.20 | -16.43 | -24.57 |
| DPS(Rs) | - | - | - | - | - |
| Book NAV/Share(Rs) | 137.48 | 137.73 | 143.12 | -37.34 | 27.23 |
| Tax Rate(%) | 201.90 | 363.53 | 25.60 | -1.36 | -9.54 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | -3.53 | -20.68 | -1.90 | 11.70 | 4.68 |
| EBIT Margin(%) | 0.89 | 3.64 | 234.47 | 6.27 | -0.68 |
| Pre Tax Margin(%) | 0.26 | 2.70 | 208.46 | -22.02 | -32.66 |
| PAT Margin (%) | -0.26 | -7.12 | 155.09 | -22.32 | -35.77 |
| Cash Profit Margin (%) | 6.19 | 1.14 | 161.39 | -15.36 | -27.66 |
| Performance Ratios | |||||
| ROA(%) | -0.11 | -2.12 | 74.05 | -10.69 | -13.36 |
| ROE(%) | -0.18 | -3.92 | 332.85 | - | -75.26 |
| ROCE(%) | 0.59 | 1.94 | 217.12 | 5.36 | -0.38 |
| Asset Turnover(x) | 0.40 | 0.30 | 0.48 | 0.48 | 0.37 |
| Sales/Fixed Asset(x) | 0.43 | 0.36 | 0.54 | 0.51 | 0.41 |
| Working Capital/Sales(x) | 3.23 | 2.04 | 3.93 | 24.27 | 8.90 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 2.32 | 2.79 | 1.86 | 1.95 | 2.46 |
| Receivable days | 37.70 | 54.62 | 43.66 | 42.68 | 52.75 |
| Inventory Days | 121.93 | 159.84 | 101.55 | 89.66 | 76.86 |
| Payable days | 262.50 | 297.63 | 335.05 | 397.33 | 545.38 |
| Valuation Parameters | |||||
| PER(x) | - | - | 0.84 | - | - |
| PCE(x) | 21.10 | 123.40 | 0.81 | -10.80 | -4.46 |
| Price/Book(x) | 0.88 | 0.79 | 1.04 | -4.75 | 4.02 |
| Yield(%) | - | - | - | - | - |
| EV/Net Sales(x) | 1.12 | 1.00 | 0.54 | 2.83 | 2.43 |
| EV/Core EBITDA(x) | 108.89 | -9.89 | -160.66 | 20.44 | 23.70 |
| EV/EBIT(x) | 123.46 | 26.56 | 0.22 | 43.08 | -358.28 |
| EV/CE(x) | 0.72 | 0.53 | 0.21 | 1.50 | 0.85 |
| M Cap / Sales | 1.33 | 1.44 | 1.37 | 1.74 | 1.23 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 21.57 | -30.44 | 5.83 | 14.84 | 19.13 |
| Core EBITDA Growth(%) | 112.39 | -1,972.34 | -102.58 | 55.10 | 143.60 |
| EBIT Growth(%) | -70.66 | -98.94 | 3,867.47 | 1,212.62 | -102.45 |
| PAT Growth(%) | 95.54 | -103.13 | 837.56 | 24.88 | -618.75 |
| EPS Growth(%) | 96.47 | -103.08 | 830.09 | 23.97 | -614.93 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.02 | 0.02 | 0.04 | -3.58 | 4.45 |
| Current Ratio(x) | 1.57 | 1.71 | 1.23 | 1.06 | 1.10 |
| Quick Ratio(x) | 0.99 | 1.09 | 0.95 | 0.67 | 0.86 |
| Interest Cover(x) | 1.41 | 3.89 | 9.01 | 0.22 | -0.02 |
| Total Debt/Mcap(x) | 0.03 | 0.03 | 0.04 | 0.75 | 1.11 |
Compare Financial Ratios of peers of PANACEA BIOTEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PANACEA BIOTEC | ₹2,608.0 Cr | 5% | -1.2% | 52.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹387,792.0 Cr | 2.3% | -0.4% | -12.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,986.0 Cr | 0% | 1.1% | 10.7% | Stock Analytics | |
| CIPLA | ₹127,124.0 Cr | 2.1% | 3.5% | -4.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹120,700.0 Cr | -1.2% | -1.7% | 4.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,868.0 Cr | 5.3% | 7.9% | -2% | Stock Analytics | |
PANACEA BIOTEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PANACEA BIOTEC | 5% |
-1.2% |
52.9% |
| SENSEX | 1.5% |
1.6% |
0.4% |
You may also like the below Video Courses
